CCL19 and diabetic kidney disease: The results in the Woroniecka Diabetes Glom dataset of Nephroseq database also proved that the expression levels of CCL19 and IL7R were significantly increased, whereas the expression levels of GHR, FGF1, FYN, VEGFA, F2R, TGFBR3, PTGDS, FGF9, and SEMA5A were significantly decreased in the DKD group.